Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taipei Exchange (TPEx: 6446) and are expanding our global presence with operations in the U.S., Japan, China and Korea, along with a world-class biologics production facility in Taichung, Taiwan. Strong hands-on experience with primary human immune cell and cancer cell line culture, T cell transfection via mRNA electroporation, cell immunophenotyping using multicolor flow cytometry, cytotoxicity assays, multiplex ELISA, live-cell analysis using incucyte system.